BR112013005444A2 - composto de pirazoloquinolina - Google Patents
composto de pirazoloquinolinaInfo
- Publication number
- BR112013005444A2 BR112013005444A2 BR112013005444A BR112013005444A BR112013005444A2 BR 112013005444 A2 BR112013005444 A2 BR 112013005444A2 BR 112013005444 A BR112013005444 A BR 112013005444A BR 112013005444 A BR112013005444 A BR 112013005444A BR 112013005444 A2 BR112013005444 A2 BR 112013005444A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrazoloquinoline compound
- pyrazoloquinoline
- compound
- Prior art date
Links
- -1 pyrazoloquinoline compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010200403 | 2010-09-07 | ||
JP2010-200403 | 2010-09-07 | ||
PCT/JP2011/070410 WO2012033144A1 (ja) | 2010-09-07 | 2011-09-07 | ピラゾロキノリン化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013005444A2 true BR112013005444A2 (pt) | 2017-09-19 |
BR112013005444B1 BR112013005444B1 (pt) | 2019-07-09 |
Family
ID=45810740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013005444-1A BR112013005444B1 (pt) | 2010-09-07 | 2011-09-07 | Composto de pirazoloquinolina |
Country Status (18)
Country | Link |
---|---|
US (1) | US8822448B2 (pt) |
EP (1) | EP2615089B1 (pt) |
JP (1) | JP5888237B2 (pt) |
KR (1) | KR101860583B1 (pt) |
CN (1) | CN103097383B (pt) |
BR (1) | BR112013005444B1 (pt) |
CA (1) | CA2810696C (pt) |
CY (1) | CY1117547T1 (pt) |
DK (1) | DK2615089T3 (pt) |
EA (1) | EA023493B1 (pt) |
ES (1) | ES2583528T3 (pt) |
HR (1) | HRP20160473T1 (pt) |
HU (1) | HUE028038T2 (pt) |
MX (1) | MX2013002584A (pt) |
PL (1) | PL2615089T3 (pt) |
RS (1) | RS54834B1 (pt) |
SI (1) | SI2615089T1 (pt) |
WO (1) | WO2012033144A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9169246B2 (en) * | 2011-09-26 | 2015-10-27 | Sanofi | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
SI2573073T1 (sl) * | 2011-09-26 | 2015-02-27 | Sanofi | Pirazolokinolinonski derivati, njihova priprava in njihova terapevtska uporaba |
JP6042060B2 (ja) * | 2011-09-26 | 2016-12-14 | サノフイ | ピラゾロキノリノン誘導体、その調製および治療上の使用 |
ES2568015T3 (es) | 2011-10-07 | 2016-04-27 | Eisai R&D Management Co., Ltd. | Derivado de pirazoloquinolina como inhibidores de PDE9 |
CN102786525B (zh) | 2012-08-08 | 2014-12-17 | 中山大学 | N-取代吡唑并[3,4-d]嘧啶酮类化合物、其制备方法及其应用 |
EP2982675B1 (en) | 2013-04-05 | 2017-08-16 | Eisai R&D Management Co., Ltd. | Salt of pyrazoloquinoline derivative, and crystal thereof |
MX363258B (es) * | 2013-04-05 | 2019-03-19 | Eisai R&D Man Co Ltd | Compuestos piridinilpirazoloquinolina. |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
AR102849A1 (es) * | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | Compuesto de piridina bicíclica |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
AU2018276565A1 (en) | 2017-06-01 | 2019-11-07 | Eisai R&D Management Co., Ltd. | Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil |
MX2019013383A (es) | 2017-06-01 | 2020-02-20 | Eisai R&D Man Co Ltd | Agente terapeutico para la demencia que combina derivado de pirazoloquinolina y memantina. |
US11484502B2 (en) | 2017-06-01 | 2022-11-01 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition comprising PDE9 inhibitor |
IL270357B2 (en) | 2017-06-01 | 2024-02-01 | Eisai R&D Man Co Ltd | A therapeutic agent in Lewy body disease containing pyrazoloquinoline compounds |
IL312114A (en) | 2021-10-14 | 2024-06-01 | Incyte Corp | Quinoline compounds as Kras inhibitors |
AU2023235233A1 (en) | 2022-03-14 | 2024-09-12 | Slap Pharmaceuticals Llc | Multicyclic compounds |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192768A (en) | 1990-09-14 | 1993-03-09 | Kyowa Hakko Kogyo Co., Ltd. | Pyrazoloquinoline derivatives |
JPH05132484A (ja) * | 1991-04-26 | 1993-05-28 | Otsuka Pharmaceut Factory Inc | ピラゾロキノリン及びピラゾロナフチリジン誘導体 |
KR20040053210A (ko) | 2001-11-02 | 2004-06-23 | 화이자 프로덕츠 인크. | Pde9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료 |
HN2002000317A (es) | 2001-11-02 | 2003-05-21 | Pfizer | Inhibidores de pde9 para tratamiento de trastornos cardiovasculares |
DE10238723A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Phenyl-substituierte Pyrazolyprimidine |
EP1581535B3 (en) | 2003-01-09 | 2009-09-02 | Astellas Pharma Inc. | Pyrrolopyridazine derivatives |
AR045689A1 (es) | 2003-05-29 | 2005-11-09 | Millennium Pharm Inc | Compuestos derivados de 2,5-dihidro-pirazolo[4,3-c]quinolin-4-ona como inhibidores de chk-1 y composiciones farmaceuticas que los contienen |
JP2006045118A (ja) * | 2004-08-04 | 2006-02-16 | Mochida Pharmaceut Co Ltd | 新規ピラゾロキノロン誘導体 |
ES2526701T3 (es) | 2005-06-14 | 2015-01-14 | Aska Pharmaceutical Co., Ltd. | Derivado de tienopirimidina |
US7671069B2 (en) | 2006-03-30 | 2010-03-02 | Chemocentryx, Inc. | Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7 |
ES2581573T3 (es) | 2006-08-08 | 2016-09-06 | Aska Pharmaceutical Co., Ltd. | Derivado de quinazolina |
US8299080B2 (en) * | 2006-12-13 | 2012-10-30 | Aska Pharmaceutical Co., Ltd. | Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor |
JPWO2008072778A1 (ja) | 2006-12-13 | 2010-04-02 | あすか製薬株式会社 | 尿路系疾患の処置剤 |
RS52166B (en) | 2007-05-11 | 2012-08-31 | Pfizer Inc. | AMINO-HETEROCYCLIC COMPOUNDS |
JP5498392B2 (ja) | 2007-11-30 | 2014-05-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 1,5−ジヒドロ−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体及びcns障害の治療のためのpde9aモジュレーターとしてのそれらの使用 |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
NZ590788A (en) | 2008-09-08 | 2012-11-30 | Boehringer Ingelheim Int | Pyrazolopyrimidines and their use for the treatment of cns disorders |
US9259564B2 (en) | 2009-01-22 | 2016-02-16 | Avent, Inc. | Enteral feeding assembly with lock assembly |
TWI404721B (zh) | 2009-01-26 | 2013-08-11 | Pfizer | 胺基-雜環化合物 |
-
2011
- 2011-09-07 CN CN201180043183.XA patent/CN103097383B/zh not_active Expired - Fee Related
- 2011-09-07 DK DK11823618.1T patent/DK2615089T3/en active
- 2011-09-07 WO PCT/JP2011/070410 patent/WO2012033144A1/ja active Application Filing
- 2011-09-07 SI SI201130826A patent/SI2615089T1/sl unknown
- 2011-09-07 KR KR1020137005776A patent/KR101860583B1/ko active IP Right Grant
- 2011-09-07 PL PL11823618.1T patent/PL2615089T3/pl unknown
- 2011-09-07 JP JP2012533012A patent/JP5888237B2/ja not_active Expired - Fee Related
- 2011-09-07 EA EA201390353A patent/EA023493B1/ru not_active IP Right Cessation
- 2011-09-07 BR BR112013005444-1A patent/BR112013005444B1/pt not_active IP Right Cessation
- 2011-09-07 CA CA2810696A patent/CA2810696C/en active Active
- 2011-09-07 HU HUE11823618A patent/HUE028038T2/en unknown
- 2011-09-07 RS RS20160364A patent/RS54834B1/sr unknown
- 2011-09-07 ES ES11823618.1T patent/ES2583528T3/es active Active
- 2011-09-07 MX MX2013002584A patent/MX2013002584A/es active IP Right Grant
- 2011-09-07 EP EP11823618.1A patent/EP2615089B1/en active Active
-
2013
- 2013-03-07 US US13/788,907 patent/US8822448B2/en active Active
-
2016
- 2016-05-04 HR HRP20160473TT patent/HRP20160473T1/hr unknown
- 2016-05-24 CY CY20161100451T patent/CY1117547T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2615089A4 (en) | 2014-01-01 |
SI2615089T1 (sl) | 2016-08-31 |
ES2583528T3 (es) | 2016-09-21 |
PL2615089T3 (pl) | 2016-10-31 |
EP2615089B1 (en) | 2016-04-27 |
CA2810696C (en) | 2018-09-18 |
WO2012033144A1 (ja) | 2012-03-15 |
HRP20160473T1 (hr) | 2016-07-29 |
EP2615089A1 (en) | 2013-07-17 |
JPWO2012033144A1 (ja) | 2014-01-20 |
CN103097383A (zh) | 2013-05-08 |
RS54834B1 (sr) | 2016-10-31 |
BR112013005444B1 (pt) | 2019-07-09 |
US20130225553A1 (en) | 2013-08-29 |
KR20130106358A (ko) | 2013-09-27 |
EA201390353A1 (ru) | 2013-08-30 |
CY1117547T1 (el) | 2017-04-26 |
MX2013002584A (es) | 2013-04-29 |
KR101860583B1 (ko) | 2018-05-23 |
CN103097383B (zh) | 2015-09-16 |
HUE028038T2 (en) | 2016-11-28 |
JP5888237B2 (ja) | 2016-03-16 |
CA2810696A1 (en) | 2012-03-15 |
DK2615089T3 (en) | 2016-06-06 |
US8822448B2 (en) | 2014-09-02 |
EA023493B1 (ru) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6900145A2 (es) | Compuesto de ciclopropanoamina | |
CO6920292A2 (es) | Compuesto de quinolona | |
DOP2012000224A (es) | Compuesto heterociclico | |
BR112013005444A2 (pt) | composto de pirazoloquinolina | |
BR112013009935C8 (pt) | compostos | |
BR112013003753A2 (pt) | compostos | |
CO6910200A2 (es) | Derivado de pirazoloquinolina | |
BR112013013263A2 (pt) | conjunto de conexão | |
BR112012028556A2 (pt) | Indóis | |
DE102011100241A8 (de) | Nitridhalbleiterbauteil | |
DK3225404T3 (da) | Fluidpatron | |
CR20130111A (es) | Triazina-oxidiazoles | |
DE10170954T8 (de) | Mikrowellendruckgarer | |
DK2648516T3 (da) | Substituerede pyridinon-pyridinylforbindelser | |
DE112011104226A5 (de) | Käfigmutter | |
CO6801726A2 (es) | Compuestos | |
DE102011117046A8 (de) | Doppelkupplungswindungsgetriebe | |
BR112013013912A2 (pt) | compostos de triazolopiridina | |
DE112011102080A5 (de) | Kupplungszentralausrücker | |
DK2442899T3 (da) | Rotorskive | |
DK2539163T3 (da) | Dækventil | |
DE102011002623A8 (de) | Ventilsteuerzeitversteller | |
DE112011102711A5 (de) | Hydrostataktor | |
DK2448659T3 (da) | Rotorskive | |
DK2447426T3 (da) | Vaske-WC |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2011, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2011, OBSERVADAS AS CONDICOES LEGAIS |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |